RxDoctor Payments Data

Morgan Adelman

Physician Assistant · Chandler, AZNPI 1760009849

Payments from drug & device makers

$1,899in general payments, 2019–2025

Across 102 payments — averaging $18.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$369
  • AbbVie$209
  • Lilly USA, LLC$186
  • Johnson & Johnson$125
  • Pfizer$102
  • Boehringer Ingelheim$102
  • plus $805 from 24 others

What the payments were for

  • Food & beverage$1,88199%
  • Entertainment$171%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,899 in reported general payments places this provider in the 75th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$118,999
Medicare patients
409
Services billed
1,460

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide39$49,273
TrulicityDulaglutide18$19,620
JardianceEmpagliflozin12$18,941
FarxigaDapagliflozin Propanediol17$17,976
MounjaroTirzepatide15$16,094
Trelegy ElliptaFluticasone/Umeclidin/Vilanter17$13,573
Spiriva HandihalerTiotropium Bromide12$6,239
Breo ElliptaFluticasone/Vilanterol11$4,547
Albuterol Sulfate HfaAlbuterol Sulfate56$1,719
PaxlovidNirmatrelvir/Ritonavir11$1,367
Ezetimibe40$1,339
Rosuvastatin Calcium70$834
Atorvastatin Calcium102$806
Famotidine36$751
Levothyroxine Sodium77$625

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$369$49,27339 claims
Lilly USA, LLCTrulicity, Mounjaro$186$35,71533 claims
Boehringer IngelheimJardiance$102$18,94112 claims
GSKTrelegy Ellipta, Breo Ellipta$95$18,12028 claims
AstraZenecaFarxiga$66$17,97617 claims
PfizerPaxlovid$102$1,36711 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Chandler

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →